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ABSTRACT 
 
Listeria monocytogenes is a Gram-positive facultative intracellular pathogen. This 
species is a common cause of food-borne illness outbreaks with high fatality rates. L. 
monocytogenes is known to produce a number of virulence factors, including enzymes 
and toxins, that are involved in the disease process. The arginine deiminase pathway has 
the ability to regulate acidic environments by converting arginine to ammonia, ornithine, 
and ATP. With the help of a membrane-bound antiporter, the ornithine is transported out 
of the cell while the ammonia is converted to ammonium. The ATP by-product can also 
be used with the F0F1-ATPase system to help maintain homeostasis. The prfA gene, 
which codes for the PrfA protein, is considered to be a crucial virulence regulator in L. 
monocytogenes. The PrfA protein has the ability to bind to palindromic promoter boxes 
within the chromosome in order to recruit necessary components for transcription of ten 
crucial virulence factors. This study attempted to produce genetic knockouts of the prfA 
gene and ADI pathway. The splicing overlap extension polymerase chain reaction 
method was used for genetic manipulation in this study. The 6.9 kb shuttle vector pKSV7 
was used to introduce the spliced genetic insert into the wild type strain. The pKSV7-AD 
vector for the Δarc was successfully introduced into L. monocytogenes. The integration 
of the plasmid into the host chromosome was also successful; however the plasmid did 
not integrate with the gene of interest. The attempted Δarc was unsuccessful due to the 
inability of the spliced SoeAD-pKSV7 insert to bind to the gene of interest. The pKSV7-
AD vector for the attempted ΔprfA successfully incorporated into the L. monocytogenes 
chromosome. The prfA SoeAD-pKSV7 inserted in the correct gene of interest, resulting 
in a successful mutant strain. 
 
Key words: Listeria monocytogenes; transformation; virulence; prfA; arginine 
deiminase; SOEing; listerosis; pKSV7, knock-out  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Listeria monocytogenes background 
Listeriosis, a condition caused by L. monocytogenes infection, has been ranked as 
the third most fatal food-borne illness in the United States (1). After a series of food-
borne illness outbreaks during the 1980s, L. monocytogenes became a widely studied 
pathogenic species (2). The disease has a 20-40% fatality rate in humans, which is higher 
than most food-borne illnesses (3, 4). As of 2011 in the U.S., L. monocytogenes was the 
third most fatal food-borne illness, with a 19% fatality rate (1). The two most fatal food-
borne illnesses recorded were Salmonella (28%) and Toxoplasma gondii (24%) (1).  
Listeriosis can occur in various mammals, affecting the central nervous system, 
bloodstream, or the uterus during pregnancy. Other species of Listeria, L. inovii and L. 
seeliger, have been known to cause listeriosis, but this event rarely occurs (2, 5). In most 
human cases of infection, individuals are immunocompromised or pregnant (2, 6–8).  
Pregnant women infected with the disease usually exhibit mild flu-like symptoms or are 
asymptomatic (2). The infected fetus, however, is often lost to miscarriage or born with a 
neonatal case of listerosis (2). Patients in the neonatal stage have also been known to 
contract the bacterium via cross-contamination (9). Pregnant women make up about 17-
24% of clinical cases with about 28% of cases resulting in abortion or stillbirth (2). 
Human immunodeficiency virus (HIV)-infected individuals have a high infection rate 
with L. monocytogenes, due to their immunocompromised state (9). This fact results in 
many underprivileged countries with high HIV rates also having elevated listerosis rates 
(9).  
Human cases are primarily contracted via ingestion, although contact with 
infected animals or humans can sometimes result in infection and disease (2). Clinical 
presentation of the diseased state varies between 1-90 days post infection, with an 
average of 30 days (2, 10). Cases of human infection have a peak season in the fall or late 
summer. However, livestock peak season usually occurs in the spring (2). Infection can 
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also occur in livestock, including sheep and goats, and most commonly results in 
encephalitis, miscarriage, or septicemia (2). This can result in significant economic loss 
due to rapid transmission through livestock. The disease is easily treated with combined 
antibiotic therapy. The accepted form of antibiotic therapy is combined treatment with 
ampicillin and gentamicin (2). Listeria species show resistance to cephalosporins, 
aztreonam, pipemidic acid, and dalfopristin/quinupristin sulfamethoxazole (2).  
Although most individual infections with L. monocytogenes are sporadic, there 
have been concentrated food-borne outbreaks documented around the world (2, 4, 6, 7). 
Many foods have been associated with listerosis outbreaks (Table 1). The infectious dose 
of L. monocytogenes is unknown and likely varies among patients (2). The average 
contamination level of foods ingested by affected patients is 102-106 CFUs/ml/g (2, 11). 
Some countries accept foods containing below 100 CFUs/g (2). The United States, 
however, has a no-tolerance policy for the presence of L. monocytogenes in any food (2, 
11). Commonly contaminated foods can be seen in Table 1. L. monocytogenes is 
ubiquitous in the environment, and contamination can occur in foods grown in soil (7). 
Listeria survive as saprophytes in soil, vegetation, and water, and upon ingestion can 
move to a replicating phase (2). 
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Table 1. Foods associated with L. monocytogenes infections 
 
Dairy Meats Fish Vegetables 
Soft Cheese Cooked Chicken Shellfish Coleslaw 
Milk Turkey Frankfurters Shrimp Vegetable rennet 
Ice Cream Sausages Smoked Fish Salted Mushroom 
Butter Pate and Rillettes Cod Roe Alfalfa 
 
Foods that have been correlated with L. monocytogenes contamination and 
food-borne illness (2, 4, 6, 12). L.monocytogenes is ubiquitous in the 
environment; however most mass outbreaks occur due to contaminated foods. 
Source(s): Liu D. 2008. The Handbook of Listeria Monocytogenes. Taylor Fr. 
Gr. 6. 
 
 
1.2 Morphology and physiology 
 All members of the genus Listeria are Gram-positive rods, with a cell size of 
about 0.4-0.5 μm wide by 1-2 μm long (2, 13–15). The cell wall is comprised of a 
peptidoglycan multilayer with mesodiaminopimelic acid (meso-DAP), which is typical of 
Gram-positive bacteria (8, 16). The ribotol, lipotechoic acids, and flagella antigens 
determine the various serotypes of L. monocytogenes (2). The bacteria are motile via 5-6 
peritrichous flagella that are uniformly distributed around the cell (2, 7, 16). Motility is 
most active between 20-25°C, and lost at 37°C (2). L. monocytogenes is a facultative 
anaerobe and a neutrophile (2, 7, 16). Listeria are generally unchallenging to grow as 
they only require biotin, thiamine, riboflavin, thioctic acid, and some amino acids (2). 
Therefore the species grows well on non-selective media (2). However, it has been shown 
that brain-heart infusion broth provides the best nutrients for growth (8, 12, 13, 17, 18). 
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Blood agar plates are the best solid selective medium for the species and help identify 
Listeria due to hemolytic virulence factors (2). The production of virulence factor 
phospholipase-C creates blue-turquoise colonies on media containing L- α -
phosphatidylinositol, which is another identifying characteristic of the bacterium (14, 18). 
L. monocytogenes has the ability to survive extreme conditions including high pH, 
extreme temperatures, and high salt concentrations (4, 6, 8, 12, 18). The bacterium has 
efficient stress response mechanisms that allow regulation and survival in extreme 
situations (6, 12).  
 L. monocytogenes is a widely studied bacterial species because of its virulence 
capabilities, but not all serotypes express the same virulence (18). Only three serotypes 
are associated with human clinical cases: 1/2a, 1/2b, and 4b (19).  The French Centre 
National de Référence des Listeria explored the infection levels of L. monocytogenes 
serotypes between 2001-2003 in human clinical cases by characterizing the serotypes 
from multiple sources, and they found that serotype 4b caused 49% of human clinical 
cases (2). The 1/2a serotype was the second highest cause of clinical cases at 27% (2). 
The Agence Française de Sécurité Sanitaire in Maisons-Alfort, France combined 
voluntary submissions of strains isolated from foods to determine percentages of 
serotypes. They discovered that the 1/2a strain was the most frequent contaminating 
serotype found in foods (64%), and was significantly higher than the second highest 
(1/2c) at 12% (2). The 1/2a strain is usually responsible for human clinical cases related 
to food-borne illness (19). 
 
1.3 Virulence 
 Virulence factors are crucial for the ability of L. monocytogenes to proliferate in a 
mammalian host (4, 8, 12, 14, 20). When the bacteria are ingested they enter host 
immune cells, multiply, and spread to neighboring cells (7, 12, 14). L. monocytogenes has 
several virulence factors that allow it to survive environments other species cannot (7, 
12). When the host ingests L. monocytogenes, the bacterium moves to hostile pH levels in 
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the stomach, and then to the intestinal lumen (7, 8, 21). Here the bacterium invades 
intestinal mucosa by route of M cells within Peyer’s patches and intestinal endothelial 
cells (2). The bacteria can multiply there before entering the circulatory system. In the 
blood and lymph systems, the bacterium comes into contact with macrophages of the 
liver, where most invading cells are destroyed (2, 18). However, those that survive move 
to phagocytic cells of the spleen, where they are internalized (2, 21).   
Phagocytic cells take in foreign particles and place them in an intracellular 
vacuole that will degrade them (2, 12, 14). L. monocytogenes escapes this vacuole and 
multiplies in the cytoplasm (2, 6, 7). The bacterial cell induces polymerization of actin, 
causing structures known as actin comet tails to form (18). These comet tails are used to 
propel the bacterium from the cytoplasm to the cell membrane, where it is propelled out 
of the phagocytic cell, while acquiring a portion of the host membrane before entering the 
next phagocytic cell (2, 18). As it enters the second phagocytic cell, it is engulfed by an 
internal vacoule, resulting in a double membrane surrounding the bacterial cell (6). When 
the outer layer of the double membrane is lysed, a new infection cycle will occur. The 
ability of L. monocytogenes to evade the immune system results in a disease state in the 
host.  
 There are three important stress factors that L. monocytogenes can withstand: 
heat, acid, and osmotic stress (4–6). The ability to withstand these obstacles allows the 
bacteria to survive many common food processing measures, which leads to food-borne 
outbreaks (2). The virulence factors are particularly important in surviving the host 
infection cycle. Heat stress occurs when L. monocytogenes moves from a external 
environment into the host body, and again at numerous stages in its infectious cycle (5). 
This stress can be regulated by a series of heat-shock proteins (HSPs) that work to re-fold 
proteins during heat degradation (8, 14, 21). Unique to L. monocytogenes is its ability to 
regulate highly acidic conditions.  
The bacterium faces acidic stress due to low pH and weak organic acids in its 
surroundings (6, 7). L. monocytogenes, like many other bacteria, is a neutrophile with an 
optimum pH of 6 or 7 (2). The species has evolved the ability to regulate pH to maintain 
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stability using a variety of factors (6). L. monocytogenes primarily uses glutamate 
decarboxylase, F0F1-ATPase system, and the arginine deiminase pathway (6, 20). The 
glutamate decarboxylase (GAD) system works by irreversibly converting a molecule of 
external glutamate to γ-aminobutyrate (GABA) (6, 20). This removes some intracellular 
protons, helping to maintain pH homeostasis. The F0F1-ATPase system in L. 
monocytogenes actively moves protons out of the cell to regulate pH (4–7). The final acid 
stress mechanism is the regulation of the arginine deiminase (ADI) system (6). High 
levels of arginine are secreted by the host cell into the phagosome where the pathogen is 
sequestered (6). This pathway allows the conversion of arginine to ornithine, carbon 
dioxide, and ammonia (6, 12, 16, 20, 21). This prevents death of the bacteria in hostile 
pH levels because it produces a less acidic environment. 
 
1.4 Arginine deiminase (ADI) pathway molecular background 
Three primary molecules are used in the ADI pathway regulation: arginine 
deiminase, catabolic ornithine carbamoyltransferase (cOTCase), and carbamate kinase 
(CK) (6, 20). For every mole of arginine catabolized by cOTCase, two moles of ammonia 
and one mole of ATP are produced (6, 20). These products can combine with intracellular 
protons to create ammonium ions, increasing the pH inside the cell (6, 20). The ornithine 
that is produced in the pathway is moved out of the cell in an energy-independent 
mechanism via a membrane-bound antiporter (6, 20). The ATP produced in the pathway 
can be fed into the F0F1-ATPase system, furthering the intracellular pH balance (6, 20).  
The genes that control the arginine deiminase pathway are referred to as arc 
genes. These genes have a unique arrangement as follows: arcB, arcD, arcC, and arcA 
(20). The arcA gene is physically separate from the other arc genes by three 
uncategorized genes (20).  There are also accessory genes on both sides of the gene 
cluster. The precise function of the accessory genes is not known, but research suggests 
they aid in pathway regulation (2). A fifth gene, argR, has been associated with 
regulation of the pathway by coding for a dual regulator molecule, argR (2).  Research 
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also suggests another physically separate gene, argG, plays a role in arginine production 
and is up-regulated to increase production under stress response (2).  
Each of the genes in the arc cluster code for a protein needed in the ADI pathway; 
a summary can be seen in Table 2. The arginine deiminase enzyme is encoded by the 
arcA gene, catabolyic ornithine carbamoyltransferase (cOTCase) by the arcB gene, and 
carbomate kinase (CK) by the arcC gene (20). These three enzymes are the main 
components of the arginine deiminase pathway (2, 6, 20, 22).  The primary function of 
this pathway is to generate resistance to acidic environments. This is achieved, in part, by 
converting arginine to ornithine. There are two sources of arginine; the first is naturally 
formed within the cell from glutamate, and the second is the arginine:ornithine antiporter 
molecule, encoded by the arcD gene (20). This antiporter moves molecules of arginine 
into the cell to be catabolized. The arginine deiminase enzyme will catabolize arginine to 
citrulline, after which cOTCase will further break down the molecule to produce 
ornithine (2, 6, 23). As a byproduct of this process, 2 moles of ammonia are produced 
along with carbamoyl-P, which is dephosphorylated by CK to yield one mole of ATP (20, 
23). Carbon dioxide is also a byproduct of the catabolic reaction. The ammonia combines 
with intracellular hydrogen ions to produce ammonium ions that will increase the pH in 
order to maintain homeostasis (2). The ornithine is moved out of the cell using the 
antiporter molecule. The ATP can be fed into the F0F1-ATPase system to extrude protons 
from the cell in order to regulate homeostasis, or to aid with general microbial growth (2, 
20). The dual regulator molecule, argR, aids survival by simultaneously up-regulating 
expression of the ADI pathway and down-regulating arginine biosynthesis (20).  As 
previously mentioned, argG, which aids in arginine synthesis, is up-regulated under 
stress response (6). This seems counterproductive; however, research by Ryan et al. 
(2009) shows that an argG mutant is actually more sensitive to acid stress (6). This 
suggests that both intracellular arginine produced by L. monocytogenes and extracellular 
arginine imported to the cell are crucial to acid stress regulation (6).  
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Table 2. Arginine deiminase genes 
 
 Abbreviation Encoding Gene 
Arginine deiminase ADI arcA 
Catabolic Ornithine 
carbamoyltransferase 
cOTCase arcB 
Carbamate kinase CK arcC 
Arginine:Orinthine Antiporter - arcD 
 
The arginine pathway encodes for three enzymes and an antiporter protein. The enzymes work to break 
down arginine molecules into ornithine, NH3, ATP, and CO2. The antiporter is an intramembrane 
molecule that imports arginine and exports ornithine.  
 
In a study by Ryan et al. (2009), the arginine deiminase pathway (ADI) was 
disrupted at different loci for virulence factors. Genes were characterized by inducing 
mutant strains that had deficient forms of argD, argG, argA, and argR. The ArgD and 
argG mutant cells were starved of arginine, then briefly re-exposed to arginine medium, 
before being introduced into epithelial cells (7). The argD mutant had increased acid 
sensitivity, but the argG mutant did not show significant change (7).  The mutant strains 
were then introduced into mice, where it was found that the argA and argR mutants had 
10x less survival than the parent strain (7). These results indicate disruption of the overall 
virulence of L. monocytogenes. However, when the mutants were introduced in vivo to 
epithelial cells, no change in pathogen survival from parent strains was observed (6). This 
indicates some other virulence factor must be involved in vivo.  
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1.5 The prfA gene and PrfA regulon 
Virulence factors are critical to the ability of L. monocytogenes to carry out the 
host infection cycle. One particularly important component of this species is the prfA 
gene, which codes for the PrfA protein. PrfA is a central virulence regulator used during 
every phase of the bacterial life cycle (2, 6, 7, 13, 19). The prfA regulon can act as an 
activator or repressor of its own gene cluster as well as controlling transcription of 
several other genes (2, 19, 24). The ten core genes subject to PrfA regulation include: hly, 
mpl, actA, plcB, plcA, prfA, inlA, inlB, inlC, and hpt (2, 4, 14, 19, 25).  When L. 
monocytogenes is exposed to high stress environments such as high acidity, host 
proteolytic enzymes, bile salts, and non-specific inflammatory attacks, the stress response 
genes are turned on by sigma factor beta (σB) (2).  This factor is an accessory molecule to 
the PrfA protein and is encoded by the sigB gene (2).  
The hly gene codes for the hemolysin protein that is the determinant of 
listeriolysin O (LLO) (4, 7, 24). LLO is a hemolytic protein that is a part of the 
cholesterol dependent pore-forming toxin (CDTX) family (2, 19). Cholesterol is the 
receptor for LLO and is required for pore creation. When LLO binds to erythrocytes, 
toxin monomers oligomerize in the target cell membrane to form pores (2). Pores are also 
formed for escape from the host cell vacuole via lysis during the infection cycle (2, 19). 
When cholesterol levels are low, the ability of the protein to function is limited (2, 19). 
Studies have shown that mutants lacking the hly gene are entirely avirulent in mouse 
models (2).  
There are two phospholipases and a metalleoprotease (Mpl) that work with LLO 
to disrupt phagosome membranes (2, 7, 12). Phosphatidylinositol-phospholipase C (PI-
PLC) is an enzyme that hydrolyzes phosphatidylinositol (2, 7, 12). This enzyme is 
encoded by the plcA gene, which can be found upstream of the hly gene (2). The 
enzymatic activity of this protein aids LLO in the escape from the host vacuole. This 
molecule is characterized by a barrel domain with an active site on its c-terminal area (2, 
7, 12). The second phospholipase hydrolyzes phosphatidylcholine and is known as 
phosphatidylcholine-phospholipase C (PC-PLC) or lecithinase (2, 7, 12). This enzyme is 
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not as substrate-specific as PI-PLC. The gene plcB that codes for this enzyme is 
downstream from the hly gene (2).  Mpl helps aid in cell-to-cell spread by activating PC-
PLC with proteolytic activity (2). The PC-PLC relies on this activation by 
metalloprotease Mpl, coded by the gene mpl, to function.  
A cell-surface protein, actin-polymerization protein (ActA), aids in the 
intracellular proliferation of L. monocytogenes and is encoded by the gene actA (7, 12, 
14). The primary function of ActA is to induce an actin-based motive force through 
internalin-dependent uptake of L. monocytogenes (2, 26). After escape from the 
phagosome, a network of actin filaments and actin-binding proteins surrounds L. 
monocytogenes (2, 26–28). The protein is distributed evenly across the cell and begins to 
concentrate on one pole while more filaments are consistently growing toward the surface 
(2). This creates a motive force that pushes L. monocytogenes through the host cytoplasm 
at speeds of up to 1.5 μm/s (2). Polymerized actin structures are used to propel the 
bacterium from the cytoplasm to the cell membrane, where it is jettisoned out of the host 
cell while acquiring a portion of the host cell membrane before entering the next host cell 
(2, 7, 12).  
There are three components to ActA: the N-terminal, a central proline-rich repeat 
region, and the c-terminal (2). When L. monocytogenes enters the host, the ActA protein 
aids in its cellular uptake (2). The ActA N-terminal consists of positively charged 
particles which, upon host cell entry, bind to the negatively charged heparin-sulfate (HS) 
moiety (2). The HS moiety is part of HS proteoglycans (HSPG) found on most 
mammalian cells (2). This binding process encourages uptake by host cells, either by 
chemical signal or sufficient presentation of bacterial factors triggering phagocytosis (2). 
Mutants lacking the N-terminal of the ActA protein could not polymerize actin, showing 
that the component was necessary (29). The second component, the central proline-rich 
repeat region, is a heavily proline-saturated area. When a mutant of this portion of the 
protein was produced, the actin filaments were shorter in length and showed slower 
movement (29). The third portion of ActA is the C-terminal, which includes a membrane 
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anchor but is not involved in actin polymerization (2, 28). When mutants lacking the C-
terminal were created there was no significant impact on actin activity (29).  
Another group of proteins called internalins aid in the entry of Listeria into the 
host cell as well as in its infectious life cycle. L. monocytogenes can enter the host cell 
both passively through phagocytosis and actively through the aid of ActA and internalins 
(2, 4). InlA, encoded by the gene inlA, is a covalently bound surface protein with a C-
terminal LPXTG motif, which reacts to adhesion E-cadherin proteins to allow cell entry 
into epithelial cells via local cytoskeletal rearrangements (2, 4, 26).  The inlB gene codes 
for the InlB protein, which is non-covalently bound to the cell surface and helps facilitate 
entry into host hepatocytes, fibroblasts, and epithelioid cells (2, 26).  The final internalin 
that is regulated by PrfA is InlC, which is coded by inlC and aids in the post-intestinal 
stage of the L. monocytogenes life cycle (2). 
The final virulence factor is hexose phosphate, which is a transporter molecule 
(30). This protein is encoded by the hpt gene and is required for rapid bacterial growth in 
the host cytosol (2, 30). The protein transports phosphorylated hexose sugars to aid in the 
replication process. Mutants have shown a strong decrease in virulence capability (30). 
The gene is completely controlled by the PrfA protein (30). 
Upon host cell entry, PrfA acts as a transcriptional activator (1, 3, 5, 12).  The 
core ten genes are down-regulated during extracellular growth and are usually weakly 
active until host infection (2). The PrfA dimer activates the virulence genes using the 
palindromic promoter box, known as the “PrfA box” (7, 12, 25). The binding process of 
PrfA to the PrfA box recruits required proteins for transcription. A co-factor binds to the 
N-terminal beta-roll domain causing a conformational change that is allosterically 
transmitted to the C-terminal helix-turn-helix motif (2). This conformational change 
triggers the transcription of virulence genes (2). Usually at 30°C there is a 5’ UTR 
(untranslated region) that blocks the ribosome binding site (2). At 37°C the secondary 
structure melts to allow for PrfA translation (2).  
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There are multiple PrfA boxes that are used to regulate non-virulence associated 
homeostasis functions from about 145 genes (2). The virulence genes associated with the 
prfA regulon can be found in relation to the life cycle in Figure 1. The majority of the 
core ten virulence factors can be found close to one another on the chromosomal Listeria 
pathogenicity island 1 (LIPI-1).  The island is made up of inlA, inlB, inlC, hpt, plcA, hly, 
mpl, actA, and plcB. Although mpl, actA, and plcB are part of the LIPI-1, they also make 
up the lecithinase operon (2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  L. monocytogenes intracellular infection. Upon host cell entry [1] the bacterium is 
taken into a phagosome, which it then escapes [2]. The bacteria begin to replicate [3] followed by 
polymerization of actin comet tails [4]. The bacteria begin to take a portion of the host membrane 
while entering another host cell [5], resulting in the double vacuole [7]. Source(s): Ireton K, 
Rigano LA, Dowd GC. 2014 Role of host GTPases in infection by Listeria monocytogenes. Cell 
Microbiol. 16:1311-1320.  
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1.6 The splicing overlap extension PCR technique 
There are many methods available for the manipulation of the genomic makeup of 
bacterial species. One of the most common forms of DNA alterations is the polymerase 
chain reaction (PCR). Splicing by overlap extension PCR is a method carried out by a 
series of sequential PCRs designed to excise a gene of interest. Two sections of DNA that 
flank the gene of interest are chosen for amplification (31, 32). The primers for those two 
sequences are designed with overlapping extensions that facilitate subsequent splicing 
(31, 32). Those two amplified products are then mixed together in a PCR that creates the 
final spliced product (31, 32). That product can then be incorporated into a vector, such 
as a plasmid, for transformation and gene knockout. Visual representation of this process 
can be seen in Figure 2.  
 
  
 
 
 
 
 
 
The vector used in this study, pKSV7, was originally created for use in Bacillus 
subtilis by Smith and Youngman (33). This vector is a hybrid between pUC18-ble and 
Figure 2. Diagram of SOEing primer orientation This diagram is a representation of the 
orientation of primers used in the SOEing procedure. The SoeA, SoeB, SoeC, and SoeD primers bind 
to regions flanking the gene of interest. The final product is a spliced amplicon of the two flanking 
regions. Source(s): Kathrin Rychli , Caitriona M. Guinane , Karen Daly , Colin Hill  and PDC. 2014. 
Generation of Nonpolar Deletion Mutants in Listeria monocytogenes Using the “SOEing” Method. 
Methods Mol. Biol. 1157:85–93. 
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pBD95ts. It is a 6.9 kb shuttle vector that confers both ampicillin and chloramphenicol 
resistance (31, 33).  The pKSV7 plasmid was used to create a specific protocol of the 
SOEing method for use in L. monocytogenes by Rychli et al. (31). After the sequential 
PCR amplifications, the spliced product is integrated with the pKSV7 shuttle vector. The 
plasmid is forced back into its supercoiled conformation and ligations are confirmed with 
a transient transformation into E. coli DH5α cells (31). Electrocompetent L. 
monocytogenes are made using the penicillin treatment method, which degrades the 
Gram-positive cell wall to increase transformation efficiency (leaky-cells) (34). Cells 
prepared with this method result in transformation efficiencies up to 4 x 106 /μg of DNA 
(34).  The confirmed ligation plasmids are then introduced into L. monocytogenes to 
generate the desired mutant strains (31).  
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CHAPTER 2 
PROJECT DESIGN 
 
2.1 Project aim one 
The arginine deiminase pathway is a source of virulence capability for L. 
monocytogenes, as previously mentioned. Due to evidence that the ADI pathway controls 
a large portion of the L. monocytogenes acid survival mechanisms, this study attempted 
to create a viable arginine deiminase pathway knockout. This knockout could also be 
used in further studies exploring virulence capabilities of the species. This study 
attempted to generate a Δarc strain using the splicing by overlap extension PCR 
procedure to manipulate the L. monocytogenes genome.  
 
2.2 Project aim two 
As previously mentioned, L. monocytogenes is an infectious species due to 
abundant virulence factors (4, 8, 12).  The gene regulator PrfA controls ten crucial 
virulence factors associated with L. monocytogenes (2, 7, 12, 25). A knockout mutant 
lacking the virulence regulator PrfA could be useful for further studies. This study 
attempted to generate a ΔprfA strain using the splicing by overlap extension PCR 
procedure to manipulate the L. monocytogenes genome.  
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CHAPTER 3 
METHODS 
3.1 Primer design  
Primers were designed using the L. monocytogenes genome accession AJ002742. 
The SoeA primer is a forward primer that binds upstream of the SoeB primer (31, 32). 
SoeA also contains a 5’ enzyme restriction site that correlates with a pKSV7 restriction 
site (31, 32). SoeB is a reverse primer that binds to a region flanking the gene targeted for 
deletion (31, 32). SoeC is a forward primer that binds to a region flanking the gene 
targeted for deletion, and has a 5’ region of ~20 base pairs (bp) that is the reverse 
compliment of SoeB (31, 32). Lastly, SoeD is a reverse primer that binds downstream of 
SoeC, and contains a 5’ enzyme restriction site that correlates with a pKSV7 restriction 
site (31, 32). A version of SoeC was ordered without any of the alterations made and is 
referred to as SoeC2. SoZ is a forward primer that binds upstream of SoeA and SoeE is a 
reverse primer downstream of SoeD. When primers required a restriction site addition, a 
leader sequence was added to ensure proper incorporation. All primers were edited to 
optimal conditions by assessing GC concentration and ensuring GC clamps were present 
when possible. A summary of guidelines for creating primers can be found in Table A.1 
and specific primer design can be seen in Figure 2. 
Primers for the prfA gene were designed using the L. monocytogenes genome 
accession AJ002742. The SoeA primer includes a restriction enzyme site for BamHI, and 
SoeD includes a restriction enzyme site for HindIII. Primers designed for the ADI gene 
complex (arc) were designed using the PubMed accession AM412558. For this gene 
SoeA had a restriction enzyme site for EcoRI and SoeD had one correlating to KpnI. The 
final sequence for primers can be seen in Table 3. 
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Table 3. SOEing primers for targeting the prfA Gene and the ADI gene 
complex 
 
Target Primer Sequence 5’-3’ Length 
prfA SoeA AGAGATGGATCCGAGCAACCATCGGAACCAT 31 
prfA SoeB CGTTCATGTCTCATCCCCCAATC 
 
23 
prfA SoeC TGGGGGATGAGACATGAACGATTAGCGAACAGGCTACCGC 
 
40 
prfA SoeD GTATCCAAGCTTAAATAGAGCCGAGCTTCCCG 
 
32 
prfA SoeZ TATTCCTACAAAAAAAGGGT 20 
prfA SoeE TGCTTCTGTAAGTTCTTTAT 20 
arc SoeA GATGCGAATTCTGTGCTTGCGCCATTTGTTT 31 
arc SoeB TGTCTGCCGGAGCGAATAAAG 21 
arc SoeC TTTATTCGCTCCGGCAGACATTCGGAAGTTTGATCCGCGTG 41 
arc SoeD ATGTAGGTACCTACGACCTGTGGCACCGATA 
 
31 
arc SoeZ CCAACTGTGAACATTCTTTT 20 
arc SoeE CAGCTCCCCATTTTTTTACA 20 
 
Original primers were designed using the NCBI Primer-Blast program (35). Restriction enzyme 
binding sites for BamHI were incorporated into prfA SoeA. Restriction sites for HindIII were added to 
prfA SoeD. Restriction enzyme binding sites for EcoRI were incorporated into arc SoeA. Restriction 
sites for KpnI were added to arc SoeD.  Primers were altered to create optimal PCR conditions. 
 
 
3.2 Stock L. monocytogenes 
A KWIK-STIK™ (ATCC ® 19111™) of L. monocytogenes was plated on blood 
agar plates (BAP) and incubated overnight at 37°C. After the incubation period, isolated 
colonies were chosen from the BAP plate, and grown in overnight cultures of BHI broth. 
500 μl of overnight culture was moved to microfuge tubes with 500 μl of 50% glycerol. 
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All tubes were then stored at -80°C for stock. L. monocytogenes DNA was also extracted 
from overnight cultures using the ChargeSwitch® DNA extraction kit.  
 
3.3 Vent PCR for SoeAB and SoeCD 
A 50 μL vent polymerase chain reaction was made with the following reagents 
(31): 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp solution mix, 1.5 
μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 μL of 100mM 
MgSo4 (6mM), 5 μL DNA template (determined by concentration), and PCR-grade H2O 
up to 50 μL. Cycling conditions for the reaction can be seen in Table 4. 
 
Table 4. Thermocycler conditions for vent polymerase chain 
reactions 
 
 Temperature (°C) Time 
Initial denaturation 95  5 minutes 
Annealing (30 cycles) 
95 30 seconds 
55 30 seconds 
72 1 minute 
Final extension 72 5 minutes 
 
Vent polymerase chain reaction thermocycler conditions for SOEing reactions. Source(s): Kathrin Rychli, 
Caitriona M. Guinane, Karen Daly, and Colin Hill. 2014. Generation of Nonpolar Deletion Mutants in 
Listeria monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93. 
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Due to the complexity of the SoeC primer an extra vent PCR step was used. A 
version of the SoeC primer (SoeC2) without the additional features was placed in the vent 
PCR sample with the SoeD primer. That product was used as a DNA template, with the 
SoeC and SoeD primers, to create the desired product containing restriction sites. 
Products were verified with a 1.5% agarose gel (750 mg agarose and 50 mL of 1X TAE 
buffer) and purified using ChargeSwitch® PCR purification kit.  
 
3.4 Vent PCR for SoeAD 
 A 50μL vent polymerase chain reaction was made with the following reagents 
(31): 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp solution mix, 1.5 
μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 μL of 100mM 
MgSo4 (6mM), 5 μL SoeCD, 3 μL SoeAB, and PCR-grade H2O up to 50 μL. Cycling 
conditions for the reaction can be seen in Table 4. Products were verified with a 1.5% gel 
(750 mg agarose and 50 mL of 1X TAE buffer) and the sample was purified with 
ChargeSwitch® PCR Purification kit.  
 
3.5 Incorporating SoeAD into pKSV7 
E. coli DH5α containing pKSV7 was grown in LB-amp50 overnight at 37°C with 
consistent shaking and the plasmid was extracted using QIAprep spin miniprep kit. All 
DNA concentration measurements were performed using the NanoDrop 2000 per 
manufacturer protocol (36). Restriction digests were set up for the PrfA SoeAD product 
and pKSV7 using HindIII and BamHI FastDigest enzymes from ThermoFisher. The 
reaction for vector digestion included 1 μg of DNA, 2 μL of FastDigest buffer, 1 μL of 
each enzyme, and H20 (reaction total of 30 μL). The reaction proceeded at 37°C for 20 
minutes per manufacturer protocol. Heat inactivation was carried out at 80°C for 10 
minutes. The PCR product digestion reagents were 0.2 μg of DNA, 2 μL of FastDigest 
buffer, 1 μL of HindIII, 1 μL of BamHI, and H20 (reaction total of 30 μL). The reaction 
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proceeded at 37°C for 25 minutes per manufacturer protocol. Heat inactivation was 
carried out at 80°C for 10 minutes. 
The arc SoeAD and pKSV7 were digested using EcoRI and KpnI FastDigest 
enzymes. The pKSV7 digestion called for 1μg of DNA, 2 μL of FastDigest buffer, 1 μL 
of each enzyme, and H20 (reaction total of 30 μL). The reaction was incubated for 20 
minutes at 37°C and heat inactivated for 10 minutes at 80°C. The PCR product digestion 
reagents were 0.2 μg of DNA, 2 μL of FastDigest buffer, 1 μL of EcoRI, 1 μL of KpnI, 
and H20 (reaction total of 30 μL). The reaction proceeded at 37°C for 25 minutes per 
manufacturer protocol. Heat inactivation was carried out at 80°C for 5 minutes. All DNA 
measurements were done using the NanoDrop system. The samples were then purified 
using the ChargeSwitch® PCR Purification kit.  
For ligation the digested SoeAD and pKSV7 were mixed at three different molar 
ratios over vector: 5:1, 3:1, and 1:1 (31). Each ligation included 2 μL of 10X ligation 
buffer and 1 μL (5 Weiss U) of T4 DNA ligase. Each reaction incubated for one hour at 
22°C. The ligation reactions were purified using the microdialysis technique where a MF-
MilliporeTM membrane filter was placed in a sterile petri dish containing 20 mL of sterile 
H20 (31). The reaction was incubated at room temperature for 20 minutes, purifying the 
sample via osmosis. DNA purity and concentrations were measured on the NanoDrop. 
 
3.6 Transformation of E.coli 
 Electrocompetent DH5α E.coli (NEB #C2989K) were thawed on ice for 10 
minutes. Cuvettes (1mm) were placed on ice while cells were prepared. 1 μL of the 
ligated pKSV7 SoeAD product (10 pg/μL) was added to 25 μL of cells. The mixture was 
carefully transferred to a chilled cuvette. The sides of the cuvette were wiped down with 
a Kimwipe and the cuvette was tapped on the countertop twice before electroporating 
using the BioRad electroporator set at 1.7 kV, 200 Ω, and 25 µF. 975 μL of pre-warmed 
(37°C) SOC, a specialized recovery broth for E. coli, was immediately added to the 
mixture and pipetted twice. The contents were then transferred to a 15 mL tube and 
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rotated at 250 rpm for one hour. Unaltered pKSV7 was used as a control in conjunction 
with every transformation. From all cultures 200 μL was plated on LB-amp50 overnight at 
37°C.  
 Integration of SoeAD into the pKSV7 backbone was verified by two methods: 
plasmid extraction followed by digestion or colony PCR. For the former method plasmids 
were extracted from single colonies using the QIA spin mini-prep kit. The arc samples 
were digested with EcoRI and KpnI. The prfA samples were digested with BamHI and 
HindIII.  The reaction for vector digestion included 1 μg of DNA, 2 μL of FastDigest 
buffer, 1 μL of each enzyme appropriate to gene, and H20 (reaction total of 30 μL). The 
reaction proceeded at 37°C for 20 minutes per manufacturer protocol and verified with a 
1.5% gel. For colony PCR, single colonies were placed in 10 μL of 10% IGEPAL-G630 
and heated at 95°C for 10 minutes. That reaction was then used as the DNA template in 
the following PCR: 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp 
solution mix, 1.5 μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 
μL of 100mM MgSo4 (6mM), 5 μL of DNA template, and PCR-grade H2O up to 50 μL. 
Thermocycler settings for this reaction can be seen in Table 5. Products were verified on 
a 1.5% gel and positive plasmid extracts were also frozen (-80°C) as stock for later use. 
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Table 5. Thermocycler conditions for colony polymerase chain 
reactions 
 
 Temperature (°C) Time 
Initial denaturation 94  3 minutes 
Annealing (30 cycles) 
94 30 seconds 
50 30 seconds 
72 1.5 minute 
Hold 10 ∞  
 
Colony polymerase chain reaction thermocycler conditions. Source(s): Kathrin Rychli , Caitriona M. 
Guinane , Karen Daly , Colin Hill  and PDC. 2014. Generation of Nonpolar Deletion Mutants in Listeria 
monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93. 
 
3.7 Electrocompetent L. monocytogenes 
 L. monocytogenes was grown in 5 mL of BHI overnight at 37°C with shaking. 
Two mL of the overnight culture was added to 100 mL BHI and 0.5 M sucrose in a 500 
mL flask (31, 34). The culture was grown at 300 rpm for 5-6 hours at 37°C until an 
OD600 of 0.2 was reached (31, 34).  Optical density measurements (OD
600) were taken on 
the NanoDrop 2000 using the cell culture software, per manufacturer protocol (36). 100 
μL of 10mg/mL penicillin stock was added and the culture was incubated for 2 hours 
under the same conditions (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g 
and the supernatant was removed (31, 34). The pellet was resuspended in 90 mL of 1mM 
HEPES and 0.5 M sucrose (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g 
and the supernatant was removed (31, 34). The pellet was resuspended in 45 mL of 1mM 
HEPES and 0.5 M sucrose (31, 34). Cells were centrifuged for 10 minutes at 8,700 x g 
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and the supernatant was removed. 200 μL of 1mM HEPES and 0.5 M sucrose was added 
to resuspend the pellet. Cells were frozen at -80°C. When transformed with puc19 (10 
pg/μL) prepared electrocompetent L. monocytogenes reached transformation levels of 7 x 
105 /μg of DNA. 
 
3.8 Transformation of L. monocytogenes 
For the electroporation reaction 4 μL of the plasmid was added to 50 μL of 
electrocompetent cells. The cells were electroporated in a pre-chilled cuvette (2mm) at 
the following parameters: 2 kV, 400 Ω, and 25 μF (31).  1mL of BHI-0.5M sucrose was 
immediately added to the cells. The contents were then transferred to a 15 mL tube and 
incubated at 30°C. A control of unaltered pKSV7 was used as a control in conjunction 
with every transformation. The cells were plated on BHI-amp50 for 48 hours at 30°C.  
 
3.9 Chromosomal integration 
 Three colonies displaying antibiotic resistance were selected from the 
transformation plates. The colonies were inoculated in 10 ml BHI-cm10 broth and then 
plated on BHI-cm10. Those cultures were incubated for 24 hours at 42°C. One mL of the 
broth was moved to a fresh 9 mL of BHI-cm10, and again plated on BHI-cm10. The 
cultures were incubated for 24 hours at 42°C. This process was repeated 3 more times. 
Liquid cultures from the 5th passage were plated on BHI plates and incubated at 30°C for 
24 hours. Three to five colonies were screened for chromosomal integration using colony 
PCR with combinations of SoeZ, SoeE, SoeA, and SoeD. The colonies were also 
inoculated into 10 mL of BHI and incubated at 30°C for 24 hours.  
If no mutants were detected during colony PCR the passaging process continued 
as follows: 1 mL of the overnight culture was moved to a fresh 9 mL of BHI and 
incubated at 30°C for 24 hours in parallel with BHI plates. This process was repeated 
until a mutant could be detected. Colony patching was repeated every 5th passage until 
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chromosomal integration was detected. Single colonies were chosen and plated onto a 
BHI plate and a BHI-cm10 plate, using a template. Colonies that did not show resistance 
to chloramphenicol were extracted, amplified by colony PCR, and analyzed on a 1.5% 
gel for mutant verification. The ΔprfA and Δarc colonies were frozen at -80°C in 50% 
glycerol once integration was achieved.  
 
3.10 Verification of construct integration 
 Colony PCR was used to confirm chromosomal integration of the plasmid into the 
targeted gene of interest. Single colonies from chromosomal integration passages were 
isolated for examination. Single colonies were placed in 10 μL of 10% IGEPAL-G630, 
heated at 95°C for 10 minutes. That reaction was then used as the DNA template in the 
following PCR: 5 μL of 10X Thermopol reaction buffer (1x), 1 μL of 10mM dntp 
solution mix, 1.5 μL of each primer (20 μM), 0.5 μL of vent DNA polymerase (1 unit), 2 
μL of 100mM MgSo4 (6mM), 5 μL of DNA template, and PCR-grade H2O up to 50 μL. 
Thermocycler settings for this reaction can be seen in Table 5. Combinations of primers 
SoeZ, SoeE, SoeA, and SoeD, which flank the gene of interest, were used for verification 
(Table 3). Products were verified on a 1.5% gel and positive samples were also frozen (-
80°C) as stock for later use. 
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CHAPTER 4 
RESULTS 
4.1 Vent PCR product for SoeAB and SoeCD 
 The purified vent PCR products for both genes of interest were verified 
successfully by electrophoresis on a 1.5% agarose gel. The amplicon for the prfA gene 
SoeAB product was ~ 256 bp and the SoeCD product was ~201 bp. For the arc gene the 
SoeAB product was ~119 bp and the SoeCD was measured at ~417 bp. In order to get 
SoeCD for the arc gene a Vent PCR amplification using a SoeC primer without 
restriction sites had to be used (Primer C2). This product is referred to as SoeC2D. The 
SoeC2D product showed an amplicon at ~384 bp and was purified then used as the DNA 
template with primers SoeC and SoeD to create SoeCD. All gel readings were 
appropriate to the amplification regions and were repeated with multiple trials to verify 
results. The gel electrophoresis photos can be seen in Figure 3. 
 
 
 
 
 
 
 
 
 
Figure 3. Gel electrophoresis: SoeAB and SoeCD. The first well on each gel is a 100 bp ladder. The 
gel on the left shows vent PCR results for the prfA gene. Wells 2 and 3 show prfA SoeAB (~256 bp) 
and wells 4 and 5 SoeCD (~201 bp). The gel image on the right shows results for the arc gene vent 
PCR results. Well 2 shows arc SoeAB (~119 bp) and well 3 shows SoeCD (~ 417 bp). 
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4.2 Vent PCR product for SoeAD 
 The purified vent PCR products for both genes of interest were verified 
successfully with electrophoresis on a 1.5% agarose gel. The SoeAD product for the prfA 
gene had an amplicon at ~447 bp, which was correct based on gene mapping. The SoeAD 
product for the arc gene showed the expected amplicon at ~537 bp. The gel 
electrophoresis photos can be seen in Figure 4. 
 
  
 
 
 
 
 
 
 
 
 
4.3 Ligation and transformation into E. coli 
  The ligation product (pKSV7-AD) was electroporated into E. coli and grew on 
overnight plates of LB-amp50. The ability to grow on this media shows successful uptake 
of the pKSV7 plasmid containing ampicillin resistance. Colonies from the plates were 
Figure 4. Gel electrophoresis: SoeAD. The first well on both pictured gels is a 100 bp ladder. The gel on the 
left shows vent PCR results for the prfA gene. Wells 2 and 3 show the SoeAD product at ~447 bp. The gel image 
on the right shows results for both the prfA gene and the ADI pathway. Well 2 shows SoeAD for prfA and well 3 
shows SoeAD for the ADI gene at ~537 bp. 
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selected for plasmid extraction using the QIAprep spin miniprep kit followed by 
amplification of the SoeAD gene via PCR. The gel for prfA pKSV7-AD showed an 
amplicon of ~440 bp released from the plasmid. The gel for the arc pKSV7-AD sample 
showed an amplicon at ~520 bp. These results confirmed that the ligation product was 
correctly assembled.  The gel electrophoresis photos can be seen in Figure 5. 
 
 
 
 
 
 
 
 
 
 
4.4 Transformation of L. monocytogenes 
 The pKSV7-SoeAD plasmid was electroporated into electrocompetent L. 
monocytogenes by electroporation and the samples grew on overnight BHI-cm10 plates at 
30°C. This display of chloramphenicol resistance showed the successful uptake of the 
plasmid. Three colonies displaying resistance were moved to 42°C on BHI-cm10 plates. 
 
Figure 5. Gel electrophoresis: pKSV7-AD.  The first well on each gel is a 100 bp ladder. The gel on the left 
shows the positive prfA SoeAD insert at ~440 bp in well 4. This sample is derived from minipreped pKSV7 
from transformed E. coli and amplified with PCR using SoeA and SoeD primers. The gel image on the right 
shows colony PCR samples from pKSV7-AD ADI. The samples that show an amplicon at ~520 bp are 
considered positive. The positive samples were wells 2,3,5,8, and 10. The other wells were negative for AD 
inserts. Dim bands at the top, which are not addressed, are non-specific genomic DNA binding common in 
colony PCR. 
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4.5 Chromosomal integration 
Cultures of Δarc transformants grew in the presence of chloramphenicol at 42°C. 
The pKSV7 plasmid, which confers chloramphenicol resistance, cannot remain 
extrachromosomal at this temperature. The fact that cells survived on chloramphenicol 
plates, at this temperature, signifies the plasmid was incorporated into the chromosomal 
DNA. To see if the plasmid was incorporated into the targeted arc gene of the 
chromosome, colony PCR was performed. The Δarc DNA was extracted from colonies 
that were isolated from the 5th cell passage. The colony PCR samples were designed 
using primers that flank the arc gene of interest. Wild type colony PCR samples were run 
in parallel, as a negative control. The deletion target for the arc gene was ~1901 bp. 
Colony PCR was performed on Δarc DNA samples with the primer pair SoeZ and SoeD, 
as well as the primer pair SoeE and SoeA. All primers are shown in Table 3 and 
experimental design methods are shown in Figure 2. The use of both sets of primers 
allows examination of either side of the arc gene to check for pKSV7 integration. 
The amplicon of a wild type colony, or an Δarc I colony with no chromosomal 
integration, amplified with SoeZ and SoeD would be ~2925 bp. The Δarc colony DNA 
amplified with SoeZ and SoeD showed an amplicon at ~2925 bp. The amplicon of a wild 
type colony, or an Δarc colony with no chromosomal integration, amplified with SoeE 
and SoeA would be about 2667 bp long. The Δarc colony DNA amplified with SoeE and 
SoeA showed an amplicon at ~2667 bp. The resulting colony PCR samples were 
consistent with the expected amplicon size of the arc gene with no pKSV7 integration. 
This suggests that the construct did not integrate into the correct location on the 
chromosome. The pKSV7 plasmid is untranslatable at high temperatures, such as 42°C. 
The fact that the Δarc transformation cells were able to translate antibiotic resistance at 
42°C indicates pKSV7 had incorporated into the L. monocytogenes chromosome. The 
results of the Δarc colony PCR samples and the wild type negative controls can be seen 
in the gel image found in Figure 6.  
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Cultures of ΔprfA transformants grew in the presence of chloramphenicol at 42°C. 
As previously mentioned, pKSV7 chloramphenicol resistance is untranslatable at 42°C as 
an extrachromosomal unit. The fact that the cells survived on chloramphenicol plates, at 
this temperature, signifies the plasmid was incorporated into the chromosomal DNA. In 
order to analyze the samples for chromosomal integration of pKSV7, a colony PCR was 
designed. The deletion target for the prfA gene was ~255 bp long. The ΔprfA DNA for 
colony PCR was isolated from colonies during the 5th passage and wild type colony DNA 
was used as a negative control. DNA samples were amplified with SoeZ and SoeD 
primers, which flank the prfA deletion target. Primers are shown in Table 3 and 
experimental design is shown in Figure 2. The expected amplicon for a wild type sample, 
or a ΔprfA sample with no chromosomal integration, would be ~735 bp in length. Seven 
samples of ΔprfA colony PCR showed a amplicon at ~480 bp, which is a decrease of 
Figure 6. Gel electrophoresis: chromosomal integration Δarc.  Wells 1 and 2 contain a 1 kb and 
100 bp ladder, respectively. Well 3 shows the wild type colony DNA was amplified with the SoeZ 
and SoeD primer set at ~2925 bp, which is correct. Well 4 contains Δarc colony DNA amplified 
with the same primers at ~2925 bp. No change between the wild type and Δarc sample was 
observed. Well 5 shows wild type DNA was amplified with SoeA and SoeE at ~2667 bp, which is 
the expected band size. Well 6 shows Δarc colony DNA amplified with the same primers at ~2667 
bp. No change between the wild type and Δarc sample was observed. 
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~255 bp in comparison to the wild type strain. One ΔprfA colony PCR sample showed an 
amplicon identical to the wild type strain, signifying a non-mutant sample. These results 
can be seen in Figure 7. The knockout of the 255 bp region in the prfA gene was 
successful and ΔprfA colonies were frozen down as stock.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Gel electrophoresis: chromosomal integration ΔprfA. Well 1 contains a 100 bp 
ladder. Well 2 contains a wild type colony PCR sample amplified with the SoeZ and SoeD 
primer set. The wild type sample matches the expected amplicon of ~735 bp. Wells 3 through 10 
were ΔprfA samples amplified with the SoeZ and SoeD primer set showing an amplicon at ~480 
bp. All colonies were positive for mutant strain except for well 5, which matched the wild type. 
Dim bands in the background, which are not addressed, are non-specific genomic DNA binding 
common in colony PCR. 
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CHAPTER 5 
DISCUSSION 
 L. monocytogenes is a virulent species due to many factors produced during the 
host infection cycle (7, 16, 19). Listeria has the ability to survive and propagate 
efficiently within a host (19). Many virulence factors are responsible for survival during 
the host infection cycle. The arginine deiminase pathway helps regulate acidic 
environments to which L. monocytogenes is exposed (6, 20). This pathway has the ability 
to convert arginine to ammonia, ornithine, and ATP (6, 20). With the help of a 
membrane-bound antiporter, the ornithine is transported out of the cell while the 
ammonia is converted to ammonium, both of which help balance intracellular pH (6, 20). 
ATP by-products can also be used with the F0F1-ATPase system to help maintain 
homeostasis (6, 20).  
 The prfA gene, which codes for the PrfA protein, is considered to be a crucial 
virulence regulator in L. monocytogenes (6, 16, 37). The prfA regulon is both an activator 
and repressor of its own gene cluster (2, 19, 24). The PrfA protein has the ability to bind 
to palindromic promoter boxes within the chromosome in order to recruit necessary 
components for transcription (2, 19, 24). There are a total of 145 genes in the Listeria 
chromosome regulated by PrfA; however, there are only ten associated with virulence 
capabilities (2). The ten core genes subject to PrfA regulation are hly, mpl, actA, plcB, 
plcA, prfA, inlA, inlB, inlC, and hpt (2, 4, 14, 19, 25).  The PrfA protein is responsible for 
regulating virulence expression at every stage of the L. monocytogenes infectious life 
cycle.   
L. monocytogenes is highly immunogenic and has the potential to be used in 
vaccine production (2). Several studies have attempted to develop a killed vaccine with L. 
monocytogenes (2). Killed vaccines are bacterial cells that have been inactivated by 
chemical or physical reactions. This process has been known to destroy some bacterial 
antigens but many species treated with this method still result in immunity (2). Some 
diseases that have effective killed type vaccines include typhoid fever, cholera, plague, 
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lyme disease, and pertussis (2). However, studies using L. monocytogenes for production 
of a killed vaccine have been well documented and unsuccessful (2). There was minimal 
resistance to listerosis in mouse models infected with high doses of heat killed L. 
monocytogenes (2).  
Live attenuated vaccines have a better chance of eliciting immune resistance to 
Listeria infection. Attenuated Listeria cells have less virulence factors for infection while 
still maintaining the ability to replicate in the host. This confers immunity to listerosis at 
relatively low doses. Listeria infects antigen-presenting cells, monocytes, macrophages, 
and dendritic cells (2). Listeria bacterial antigens are presented via the MHC class I 
pathway to cytotoxic T- lymphocytes (CD8+) (2). Antigens are also presented via the 
MHC class II pathway to T-lymphocyte helper 1 cells (CD4+) (2). The ability of L. 
monocytogenes to interact with both MHC classes increases the efficiency of the live 
vaccine.  
Another potential use for attenuated Listeria could be a Listeria-based cancer 
vaccine. Anti-cancer vaccines use the host body to fight off disease. Transforming 
attenuated L. monocytogenes with cancer antigen genes can induce targeted self-reactive 
T-cells (2). Attenuated Listeria, containing cancer antigen genes, are taken up and 
degraded by phagocytic cells (13). The antigens would be presented on phagocytic cell 
surfaces via the Major Histocompatibility Complexes I and II (2). Cytotoxic T- 
lymphocytes and T-lymphocyte helper 1 cells would react with the cancer antigens and 
retarget the host immune system components. CD8+ and CD4+ T-cells have both been 
found to have highly increased levels upon interaction with L. monocytogenes (2).  This 
fact makes the species a good candidate for immunotherapy for cancer patients. This 
method is a relatively new approach to cancer and has the potential to be a much less 
debilitating form of treatment for patients. 
This study aimed to create a spliced arc gene (ADI pathway) mutant using the 
splicing by overlap extension PCR procedure. The production of SoeAB and SoeCD 
products for the arc gene were successful with amplicons at ~119 bp and ~417 bp, 
respectively. Those products were successfully spliced to create the arc SoeAD PCR 
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product with an amplicon at ~537 bp. The arc SoeAD insert was incorporated into 
pKSV7 via digestion and ligation. The arc SoeAD insert was effectively verified after 
transformation into E. coli. The arc pKSV7-AD plasmid was successfully introduced to 
the L. monocytogenes strain via transformation. The pKSV7, which confers 
chloramphenicol resistance, cannot be maintained as an extrachromosomal unit at 42°C. 
The fact that the cells grew in the presence of chloramphenicol at this temperature 
signifies that pKSV7 was incorporated into the chromosome.  
The colony PCR results, however, showed no change compared to the wild type 
strain. The wild type DNA amplified with primers SoeZ and SoeD are expected to 
produce an amplicon at ~2925 bp. If pKSV7 were incorporated into the chromosomal 
DNA sample, at the gene of interest, and the Δarc sample would be expected to yield an 
amplicon at ~9825 bp. If pKSV7 had left the chromosome with the arc deletion target, a 
mutant would yield an amplicon at ~1024 bp. The wild type DNA amplified with the 
SoeA and SoeE primers are expected to produce an amplicon at ~2667 bp. The pKSV7 
integrated with the targeted arc gene would yield an amplicon of ~9567 bp while a 
successful mutant would produce an amplicon at ~ 766 bp. The Δarc colony PCR 
amplification was identical to the negative control wild type amplification. This data 
signifies the plasmid successfully incorporated into the chromosome; however, it was not 
incorporated into the arc gene deletion target. 
This resulted in an unsuccessful attempted Δarc mutant. The failure of the arc 
pKSV7-AD to incorporate into the arc gene deletion target is likely due to an inefficient 
SoeAD product. Small mutations in the SoeAD insert sequence could have been 
introduced during the sequential PCR amplifications. This would cause correct amplicon 
bands on gel verification but would not be specific for incorporation into the gene of 
interest. The project data can still be helpful to further studies by provide an example of 
potential errors in the procedure, which could be used to make the protocol more 
efficient.  
The second goal of this study was to create a spliced prfA gene mutant using the 
splicing by overlap extension PCR procedure. The vent PCR amplification of SoeAB and 
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SoeCD produced a correct amplicon at ~256 bp and ~201 bp, respectively. Those 
products were successfully spliced to create the prfA SoeAD PCR product with an 
amplicon at ~447 bp. The prfA AD product was incorporated into the pKSV7 backbone 
via digestion and ligation. The prfA pKSV7-AD vector was verified to be correct after 
transformation into E. coli. The prfA pKSV7-AD vector was successfully introduced to L. 
monocytogenes and transformants grew in the presence of chloramphenicol at 42°C. The 
fact that the L. monocytogenes samples were able to translate chloramphenicol resistance 
at this temperature signified that the prfA pKSV7-AD was incorporated into the 
chromosome.  
Colony PCR using primers designed to flank the prfA gene deletion target was 
used to verify chromosomal integration. The L. monocytogenes wild type DNA amplified 
with primers SoeZ and SoeD would produce an amplicon at ~ 735 bp. If prfA pKSV7-AD 
were still present in the chromosome, at the gene of interest, the ΔprfA sample would 
produce an amplicon at ~7635 bp. If prfA pKSV7-AD had left the chromosome, with the 
gene of interest, a mutant would yield an amplicon at ~480 bp. The colony PCR ΔprfA 
reactions showed a decrease of ~255 bp in comparison to the wild type strain at ~ 735 bp. 
The colony PCR of ΔprfA samples corresponded directly with expected results for a 
mutant strain containing a spliced prfA gene. These results signify the plasmid left the 
host chromosome with the gene of interest. The ΔprfA strain was isolated and will be 
useful in further studies on this pathogen. 
These further studies could to examine the change in virulence capability of the 
wild type strain in comparison with successful mutant strains. This property could be 
assessed using tissue culture assays that monitor infection and survival rates. This 
comparative analysis would reveal how the loss of virulence factors affects the ability of 
L. monocytogenes to propagate in vitro. Due to thermo-activated virulence up-regulation, 
a study could also be designed to specifically investigate the differences in mutant strains 
in vitro versus in vivo in murine models, as compared to wild type L. monocytogenes. 
Comparing fatality and infection rates post-infection of each group could reveal effects of 
mutations on virulence.  
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A3 
 
 
Primer Design Guidelines 
 
Primer Location Requirements 
SoeA 
Forward primer 
Binds upstream of 
SoeB 
Contains a 5’ 
enzyme restriction 
site 
SoeB 
Reverse primer 
Binds to a region 
flanking the gene 
targeted for deletion 
N/A 
SoeC 
Forward primer 
Binds to a region 
flanking the gene 
targeted for deletion 
Contains a 5’ region 
of ~20 bp that is the 
reverse compliment 
of SoeB 
SoeD 
Reverse primer 
Downstream of SoeC 
Contains a 5’ 
enzyme restriction 
site 
SoeZ 
Forward primer 
Binds upstream of 
SoeA 
N/A 
SoeE 
Reverse primer 
Downstream of SoeD 
N/A 
 
 
 
 
 
 
 
 
Table A.1. Primers used in the SOEing method, use a method of overlap extension to incorporate the gene 
of interest into the vector of choice for gene knockout. Source(s): Kathrin Rychli , Caitriona M. Guinane , 
Karen Daly , Colin Hill  and PDC. 2014. Generation of Nonpolar Deletion Mutants in Listeria 
monocytogenes Using the “SOEing” Method. Methods Mol. Biol. 1157:85–93. 
 
